Back to results
US 2026/0218186 A1Published application
Tau splice-switching oligonucleotide and pharmaceutical composition for treating or preventing tau-related disease
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsShunya SUZUKI, Yohei NUKAGA, Yuki KUNIYOSHI, Takashi FUTAMURA
Life of this patent
Estimating the term…
Abstract
The present disclosure includes a splice-switching oligonucleotide that binds to intron 1B of TAU pre-mRNA, and a pharmaceutical composition comprising the splice-switching oligonucleotide for treating or preventing a TAU-related disease.
Claims13
A splice-switching oligonucleotide that binds to intron 1B of TAU pre-mRNA.
Dependencies are inferred from the claim text.